Bavarian Nordic has sold a PRV for $160m, a day after the FDA announced a new scheme utilising the fast-track tickets.

NHS England chair Penny Dash shared her views on European healthcare during a fireside discussion at HLTH Europe in Amsterdam ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...